Skip to main content
Quest Diagnostics

Medical Countermeasures and Systems Readiness: Diagnostics for Influenza A (H5)

NASEM Forum on Medical and Public Health Preparedness for Disasters and Emergencies

Virtual, Mar 25-26, 2025

Oral presentation: Medical Countermeasures and Systems Readiness: Diagnostics for Influenza A (H5)

Authors: Marlowe EM

Specialty: Infectious disease

Related content

Test FAQ
Influenza A (H5) Virus RNA, Qualitative Real-Time PCR, Respiratory and Conjunctiva
Publication
Prevalence and Co-Detection Rates of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus: A Retrospective Analysis
Publication
Proceedings of the Clinical Microbiology Open 2023: Discussions About Pandemic Preparedness
Audio Podcast
Disease Surveillance: Preventing the New Pandemic
Conference Presentation
Comparison of Cepheid, Roche, and LDT platforms for COVID-19 and influenza testing
Audio Podcast
The Future of Laboratory Diagnostic Medicine

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.